Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma (Q43279488)
Jump to navigation
Jump to search
scientific article published on 8 September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma |
scientific article published on 8 September 2009 |
Statements
1 reference
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma (English)
1 reference
Andrzej J Jakubowiak
1 reference
Tara Kendall
1 reference
Ammar Al-Zoubi
1 reference
Yasser Khaled
1 reference
Shin Mineishi
1 reference
Asra Ahmed
1 reference
Erica Campagnaro
1 reference
Christine Brozo
1 reference
Thomas Braun
1 reference
Moshe Talpaz
1 reference
Mark S Kaminski
1 reference
8 September 2009
1 reference
1 reference
27
1 reference
30
1 reference
5015-5022
1 reference
Identifiers
1 reference
1 reference